Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
about
Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonanceCurrent Views on Anthracycline Cardiotoxicity in Childhood Cancer SurvivorsMechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage.Diastolic function in anthracycline-treated children.Noninvasive diagnosis of chemotherapy related cardiotoxicityEvaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer.Late cardiovascular complications after hematopoietic cell transplantation.Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis.Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines.Evaluation of Endocrine Late Complications in Childhood Acute Lymphoblastic Leukemia Survivors: A Report of a Single-Center Experience and Review of the LiteratureHealth promotion for adolescent childhood leukemia survivors: building on prevention science and ehealth.Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects.Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort StudyVascular injury in cancer survivors.Childhood and adolescent cancer statistics, 2014.Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors.Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor StudyEarly left ventricular dysfunction in children after hematopoietic stem cell transplantation for acute leukemia: a case control study using speckle tracking echocardiography.Plasma high sensitivity troponin T levels in adult survivors of childhood leukaemias: determinants and associations with cardiac function.Individual prediction of heart failure among childhood cancer survivors.Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group.Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivorsNT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivorsManaging chemotherapy-related cardiotoxicity in survivors of childhood cancers.Dexrazoxane as a cardioprotectant in children receiving anthracyclinesIncidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation.Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland.Apoptosis in Anthracycline CardiomyopathyPhysical Activity, Fitness, and Cardiometabolic Risk Factors in Adult Survivors of Childhood Cancer with a History of Hematopoietic Cell TransplantationLate cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.Detection of Myocardial Metabolic Abnormalities by 18F-FDG PET/CT and Corresponding Pathological Changes in Beagles with Local Heart Irradiation.Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy.Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study.Strategies to prevent anthracycline-related congestive heart failure in survivors of childhood cancer.Impact of Tailored Education on Awareness of Personal Risk for Therapy-Related Complications Among Childhood Cancer SurvivorsEchocardiographic Detection of Cardiac Dysfunction in Childhood Cancer Survivors: How Long Is Screening Required?Electrocardiographic abnormalities and mortality in aging survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study.
P2860
Q26859193-8EEA8CF1-0711-45C3-8ECD-57E737A3D48CQ28083073-EF22841A-17BE-4030-B70E-88E4ECE803AAQ30439608-F1F52425-5DDB-4BA1-9DF4-51256D1BEA05Q30459180-96306408-1FD4-4522-9885-5616E0927B23Q30461444-3AC4578B-BE4E-4C30-A563-CC6679B2CF1DQ33590755-1D1FB87E-BE82-4F17-B481-025BEF6A3830Q33605306-3029AF1B-6B91-4365-A357-37C228C954C2Q33671281-1D1810FB-86AC-4ECB-A672-D2D4C2241159Q33739871-A809A7A0-C5D4-4490-BA86-CF63DB1BA423Q33747806-1FB27B3E-844D-4BDE-97E9-8E26FE793F75Q33793122-0769227F-34C9-481F-8F81-D0198BCE17CFQ33815037-60330A0E-CE9C-4532-B95E-3F422A3F1644Q33873865-DC86F505-D6C7-40F2-9C31-72B94AD4590FQ34193699-EC836C75-85B8-4164-BA4F-96CDD060C88DQ34211238-D50F2BAF-1A7F-486A-B9C9-D3FAD9C214FFQ34401667-069DE8A1-1728-48F0-A6BD-77A090E31FB8Q34717844-BD3EDD07-0335-4F98-8C1B-9CB1BD1C228BQ34835391-72399985-C109-4377-A8BB-BB6DA1354A7DQ35028620-169AC106-9128-4AFF-844E-6AF4EFD603D0Q35034995-62B7E906-E93A-4944-948F-7D3038A63959Q35040680-CD8574EE-9B11-4B5F-9B25-3DA821B868BEQ35049636-E194582D-62D8-4FF2-9434-63D73941C3A6Q35076156-7BEDE347-BC48-4F7C-BC78-39D8451A0EB0Q35086334-BCD8B3D2-FB36-4CE1-8E50-D0893CDD9ABFQ35327266-AE86D9C7-FEF3-42C9-A843-097B8253F3E4Q35557142-41CF4BC9-494B-4265-9CE7-7ED90A68A833Q35562745-6289CAA2-9530-498A-AF0B-3885803EA670Q35583768-6C154A93-65D8-402E-A394-47F7980C9C19Q35604039-6B403909-5086-49CF-8F01-FCA4D9E32C12Q35612851-48705819-6656-4966-B40B-A468D52BFB98Q35642302-2543FD30-5794-4038-8C48-58A09EEF23A5Q35738600-841BD033-8779-4C4F-9176-D5E1D80AB272Q35757419-999496DA-AC60-4C3E-9BED-50658F1CDA95Q35843724-4DF8EF76-40F2-43FD-9E51-768642544A3FQ35925270-49F398AD-7869-4877-9C82-62E6ED87FBAFQ36029249-A270E367-08C3-4413-A69D-84A34ED3BACCQ36184665-6DB75E2D-3547-4F69-9A60-90C9F4DDDE2FQ36297411-B06658FF-4778-42CC-965A-DEFF64CCC8ABQ36348525-C2419517-9072-4A4F-B865-E3665ADD318CQ36408363-D3A9C588-4010-4CAA-91D9-74C79D99C41F
P2860
Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Monitoring for cardiovascular ...... the Children's Oncology Group.
@en
Monitoring for cardiovascular ...... the Children's Oncology Group.
@nl
type
label
Monitoring for cardiovascular ...... the Children's Oncology Group.
@en
Monitoring for cardiovascular ...... the Children's Oncology Group.
@nl
prefLabel
Monitoring for cardiovascular ...... the Children's Oncology Group.
@en
Monitoring for cardiovascular ...... the Children's Oncology Group.
@nl
P2093
P50
P356
P1433
P1476
Monitoring for cardiovascular ...... the Children's Oncology Group
@en
P2093
Cardiovascular Disease Task Force of the Children's Oncology Group
David C Hodgson
Karen E Kinahan
Kathleen Meeske
Melissa M Hudson
Ming Hui Chen
Neyssa Marina
Sadhna M Shankar
Smita Bhatia
Wendy Landier
P304
P356
10.1542/PEDS.2007-0575
P407
P577
2008-01-10T00:00:00Z